We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

The Immune System – Products

Cancer cells.
Product News

Association for Molecular Pathology Publishes Evidence-Based Recommendations for Tumor Mutational Burden Testing

AMP published a set of evidence-based recommendations for the analytical validation and reporting of tumor mutational burden (TMB) testing as a potential predictive biomarker for immune checkpoint inhibitor (ICI) therapies.
Cell therapy.
Product News

InDevR and Sino Biological Team Up To Deliver Multiplexed Analytical Solutions for mRNA Vaccine and Cell & Gene Therapy

Partnership addresses biopharmaceutical industry’s urgent need for improved in-process and QC testing tools for these rapidly evolving application fields.
Cells.
Product News

Bruker Launches Ultimate Sensitivity timsTOF Ultra 2 To Enable New Research Paradigms in Single-Cell and Subcellular Proteomics

At the 72nd ASMS meeting, Bruker Corporation (Nasdaq: BRKR) launches the new top-of-the-line timsTOF Ultra 2 system with significantly further enhanced sensitivity for deep profiling of small cells and subcellular organelles.
Cancer cells.
Product News

Estonia Develops Personalized CAR-T Cell Therapy for Blood Cancer Patients

The Tartu University Hospital, North Estonia Medical Centre, and Icosagen have joined forces to develop and introduce an innovative personalized cell therapy (CAR-T cell therapy) for patients in Estonia.
CD2-CD58 Axis: Targets in Immune Synapse, cancer immunotherapy, autoimmune diseases, immune evasion of tumors, antiviral responses, immune rejection
Product
Advertisement

CD2-CD58 Axis: Targets in Immune Synapse

Sino Biological offers a wide range of recombinant CD2 and CD58 proteins and antibodies to support elucidating key interactions and pathways and shedding light on potential therapeutic strategies.
Cancer cells.
Product News

OncoHost To Present Poster Demonstrating PROphet®’s Application in Multiple Cancer Indications at ASCO 2024

Plasma-based proteomic platform predicts clinical benefit from immune-checkpoint inhibitors in NSCLC, melanoma, and HPV-related cancers.
The Fluidity One-M instrument with the inbuilt Microfluidic Diffusional Sizing (MDS) technology.
Product News

Fluidic Sciences Relaunches Microfluidic Diffusional Sizing—Refining Protein-Protein Interaction Analysis

Fluidic Sciences Ltd., announces its official launch as a company, and the commercial relaunch of the acquired Fluidity One-M instrument for measuring protein-protein interactions in solution—leveraging Microfluidic Diffusional Sizing (MDS) technology.
Double helix structure of DNA.
Product News

ERS Genomics and IRBM Sign CRISPR/Cas9 License Agreement

License agreement provides IRBM access to CRISPR gene editing technology to be applied across its drug discovery services offering.
 Truly Fast. Simply Effortless. The iQue ® 3 High-Throughput Screening Cytometry Platform
Product
Advertisement

Truly Fast. Simply Effortless. The iQue ® 3 High-Throughput Screening Cytometry Platform

Measure T cell activation with an optimized high-throughput cytometry assay, to aid in the rapid identification of therapeutic candidates.
A Rapid and Robust Solution for Cellular Response Characterization
App Note / Case Study

A Rapid and Robust Solution for Cellular Response Characterization

This app note explores the use of an assay to facilitate rapid monitoring of T-cell function and simultaneous assessment of cell phenotype, activation markers, proliferation, viability and cytokine secretion.
Advertisement